Viejo Moreno R, Sánchez-Izquierdo Riera J Á, Molano Álvarez E, Barea Mendoza J A, Temprano Vázquez S, Díaz Castellano L, Montejo González J C
UCI Polivalente, Servicio de Medicina Intensiva, Hospital 12 de Octubre, Madrid, España.
UCI Polivalente, Servicio de Medicina Intensiva, Hospital 12 de Octubre, Madrid, España.
Med Intensiva. 2016 Nov;40(8):483-490. doi: 10.1016/j.medin.2016.02.003. Epub 2016 Mar 23.
To improve critical patient safety in the prevention of venous thromboembolic disease, using failure mode and effects analysis as safety tool.
A contemporaneous cohort study covering the period January 2014-March 2015 was made in 4 phases: phase 1) prior to failure mode and effects analysis; phase 2) conduction of mode analysis and implementation of the detected improvements; phase 3) evaluation of outcomes, and phase 4) (post-checklist introduction impact.
Patients admitted to the adult polyvalent ICU of a third-level hospital center.
A total of 196 patients, older than 18 years, without thromboembolic disease upon admission to the ICU and with no prior anticoagulant treatment.
A series of interventions were implemented following mode analysis: training, and introduction of a protocol and checklist to increase preventive measures in relation to thromboembolic disease.
Indication and prescription of venous thrombosis prevention measures before and after introduction of the measures derived from the failure mode and effects analysis.
A total of 59, 97 and 40 patients were included in phase 1, 3 and 4, respectively, with an analysis of the percentage of subjects who received thromboprophylaxis. The failure mode and effects analysis was used to detect potential errors associated to a lack of training and protocols referred to thromboembolic disease. An awareness-enhancing campaign was developed, with staff training and the adoption of a protocol for the prevention of venous thromboembolic disease. The prescription of preventive measures increased in the phase 3 group (91.7 vs. 71.2%, P=.001). In the post-checklist group, prophylaxis was prescribed in 97.5% of the patients, with an increase in the indication of dual prophylactic measures (4.7, 6.7 and 41%; P<.05). There were no differences in complications rate associated to the increase in prophylactic measures.
The failure mode and effects analysis allowed us to identify improvements in the prevention of thromboembolic disease in critical patients. We therefore consider that it may be a useful tool for improving patient safety in different processes.
以失效模式与效应分析作为安全工具,提高危重症患者预防静脉血栓栓塞性疾病的安全性。
一项同期队列研究,涵盖2014年1月至2015年3月期间,分4个阶段进行:第1阶段)在失效模式与效应分析之前;第2阶段)进行模式分析并实施检测到的改进措施;第3阶段)评估结果;第4阶段)(引入检查表后的影响)。
一家三级医院中心的成人综合重症监护病房收治的患者。
共196例患者,年龄大于18岁,入住重症监护病房时无血栓栓塞性疾病且未接受过抗凝治疗。
在模式分析后实施了一系列干预措施:培训,并引入一项方案和检查表,以增加与血栓栓塞性疾病相关的预防措施。
引入源自失效模式与效应分析的措施前后,静脉血栓预防措施的指征和处方情况。
第1、3和4阶段分别纳入59例、97例和40例患者,分析接受血栓预防的受试者百分比。失效模式与效应分析用于检测与缺乏血栓栓塞性疾病培训和方案相关的潜在错误。开展了提高认识活动,包括工作人员培训和采用预防静脉血栓栓塞性疾病的方案。第3组预防措施的处方率有所增加(91.7%对71.2%,P = 0.001)。在引入检查表后的组中,97.5%的患者接受了预防,双重预防措施的指征有所增加(4.7%、6.7%和41%;P < 0.05)。与预防措施增加相关的并发症发生率无差异。
失效模式与效应分析使我们能够确定危重症患者预防血栓栓塞性疾病方面的改进。因此,我们认为它可能是在不同流程中提高患者安全性的有用工具。